Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 17, 2023
CN Bio announced that the FDA and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS and their applications using the PhysioMimix™ Multi-organ System.
read more
Tuesday, January 17, 2023
TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable scalable, cost-effective and efficient ...
read more
Tuesday, January 17, 2023
THREAD announced a five-year collaboration with, Sanofi. THREAD will serve as the sole provider of unified decentralized clinical trials (DCTs) and electronic clinical outcome assessments (eCOA) technology for Sanofi's Integrated Patient Platform (...
read more
Tuesday, January 17, 2023
Lonza announced two new collaborations with McSAF and Cristal Therapeutics to expand its bioconjugates offering.
read more
Tuesday, January 17, 2023
Be The Match BioTherapies® announced it is offering CIBMTR® (Center for International Blood and Marrow Transplant Research) Clinical Research Organization Services (CRO Services), which allows sponsors to significantly reduce the time required to ...
read more
Tuesday, January 17, 2023
Catalent, Inc. announced the appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America.
read more
Thursday, January 12, 2023
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative’s Terra Carta Seal.
read more
Thursday, January 12, 2023
Charles River Laboratories International, Inc. announced the launch of its eXpDNA™ plasmid platform, established from the Company’s contract development and manufacturing (CDMO) and biologics testing experience.
read more
Thursday, January 12, 2023
Eurofins CDMO Alphora Inc. announced the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.
read more
Thursday, January 12, 2023
CordenPharma is pleased to announce the signing of a multi-year agreement commencing in 2023 for the contract manufacturing of a large-volume peptide at its CordenPharma Colorado facility.
read more
Thursday, January 12, 2023
lora Pharmaceuticals announced that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC's manufacturing capabilities located in Fort Worth, TX.
read more
Thursday, January 12, 2023
The IMA Group (IMA) has completed the acquisition of Clinical Trials of America (CTA), a multi-therapeutic clinical trials company that brings to IMA four new independent and six embedded site locations in Louisiana and North Carolina.
read more
Thursday, January 12, 2023
Catalent and Ethicann Pharmaceuticals Inc. announced that the companies have executed a development and license agreement to develop Ethicann’s clinical drug pipeline using Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology.
read more
Thursday, January 12, 2023
Argonaut Manufacturing Services announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more